Charming Medical Ltd
MCTA
3 hedge funds and large institutions have $1.05M invested in Charming Medical Ltd in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0.02% less ownership
Funds ownership: 0.3% → 0.28% (-0.02%)
8% less capital invested
Capital invested by funds: $1.14M → $1.05M (-$96.9K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$96.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $732K | -$96.9K | -3,300 | -12% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $316K | – | – | – |
|
MCTA Hedge Fund Activity: Q1 2026 in Review
3 of the 8,169 institutional investors tracked by Wall St. Rank reported a position in Charming Medical Ltd (MCTA) for Q1 2026, worth a combined $1.05M — down 8.5% from $1.14M a quarter earlier.
Fund positioning in MCTA was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $96.9K.
- 3 institutional investors held Charming Medical Ltd (MCTA) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $1.05M of Charming Medical Ltd stock for Q1 2026, down 8.5% quarter-over-quarter.
- 0 funds opened new Charming Medical Ltd positions in Q1 2026 and 0 closed out.
- The largest Charming Medical Ltd seller in Q1 2026 was UBS Group, an estimated $96.9K sold.
Based on aggregated 13F filings for Q1 2026.